期刊文献+

重性抑郁发作缓解后8周和2年的疗效及其预测因素 被引量:5

The outcomes and outcome predictive factors of major depressive episodes at 8 weeks and 2 years after discharge.
下载PDF
导出
摘要 目的基于对重性抑郁发作疗效的重新定义,重新评价重性抑郁发作暂时缓解后8周和2年后的疗效并探讨其预测因素。方法采用汉密顿抑郁量表24项、贝克躁狂量表以及自编的一般情况量表,对84例经住院系统治疗于出院时已取得暂时缓解(持续缓解时间在1~7周)的抑郁发作患者进行为期2年的开放性、前瞻性的自然观察研究。结果在出院后8周,缓解(持续缓解时间≥8周)、阈下发作、症状残留、复发的患者分别占46.4%(39/84)、10.7%(9/84)、21.4%(18/84)、21.4%(18/84)。出院后2年,完全痊愈、部分痊愈、慢性化或反复发作的患者分别占39.3%(33/84)、25.0%(21/84)、35.7%(30/84)。回归分析显示,出院后8周是否达到缓解与病程有关(P=0.047,OR=0.89,β=-0.12),出院2年后是否保持痊愈状态与出院8周后是否达到缓解(P<0.001,OR=109.97,β=4.70)、治疗依从性好坏(P=0.002,OR=0.23,β=-1.46)有关;出院后8周、2年的疗效与患者的年龄、性别、是否共病、是否存在精神病性症状、发作次数、病情严重程度、家族史、单相或双相抑郁等因素无关(P>0.05)。结论重性抑郁发作急性期的治疗应以持续的缓解为目标;要取得良好的远期疗效,早期、彻底以及全程治疗是关键。 Objective To reevaluate major depressive episodes' treatment outcome at 8 weeks and 2 years after transitory remission ( remission time lasted 1 - 7 weeks) based on the redefinition of treatment outcomes for major depressive episodes (MDE) and to explore the predictive factors tbr outcomes. Methods A 2-year open, prospective and natural study was conducted on 84 inpatients with MDE who had achieved transitory remission at discharge and their outcomes were assessed using 24-item Haruilton depression rating scale (HAMD) , Bech-Rafaelsen mania scale (BRMS) and self-made questionnaire. Results At 8 weeks after discharge, 46.4% (39/84) patients remained in remission (remission time lasted 8 weeks or longer), 10. 7% (9/84) patients experienced subthreshold episode, 21.4% (18/84) patients presented residual symptoms and 21.4% (18/84) patients relapsed. At 2 years after discharge, 39. 3 % ( 33/84 ) patients completely recovered, 25.0% (21/84)patients partially recovered, 35.7% (30/84)patients had a chronic course or frequently recurred. Binary logistic regression analysis showed that remission at 8 weeks after discharge was associated with illness duration( P = 0. 047 ,OR =0. 89,β = -0. 12) , and recovery at 2 years after discharge was associated with the remission at 8 weeks after discharge ( P 〈 0. 001, OR = 109. 97 ,β = 4. 70 ) and treatment compliance ( P = 0. 002, OR = 0. 23, β = - 1.46 ). Age, sex, comorbidity, psychotic features, number of episodes, illness severity, family history, unipolar or bipolar disorder didn't significantly affect the short-term and long-term treatment outcomes ( P 〉 0. 05 ). Conclusions Remission should be the treatment goal for patients with acute MDE and good long-term outcomes for patients with MDE depend on an early, complete and whole-course treatment.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2011年第2期72-75,共4页 Chinese Journal of Nervous and Mental Diseases
关键词 重性抑郁发作 疗效 预测因素 Bipolar disorder Treatment outcome Predictive factors
  • 相关文献

参考文献13

  • 1Goodwin GW,Anderson I,Arango C,et al.ECNP Consensus meeting bipolar depression.Nice,March 2007[J].Eur Neuropsychopharmacol,2008,18(7):535-549.
  • 2Sachs GS,Nierenberg AA,Calabrese JR,et al.Effectiveness of adjunctive antidepressant treatment for bipolar depression[J].N Engl J Med,2007,356(17):1711-1722.
  • 3Furukawa TA,Fujita A,Harai H,et al.Definitions of recovery and outcomes of major depression:results from a 10-year follow-up[J].Acta Psychiatr Scand,2008,117(1):35-40.
  • 4Zimmerman M,McGlinchey JB,Posternak MA,et al.How should remission from depression be defined? The depressed patient's perspective[J].Am J Psychiatry,2006,163(1):148-150.
  • 5Kanai T,Takeuchi H,Furukawa TA,et al.Time to recurrence after recovery from major depressive episodes and its predictors[J].Psychological Medicine,2003,33(5):839-845.
  • 6杨栋,谌益华,张宏耕.影响新型抗抑郁药物疗效的相关因素[J].中国神经精神疾病杂志,2009,35(11):680-682. 被引量:10
  • 7McKinnon MC,Yucel K,Nazarov A,et al.A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder[J].J Psychiatry Neurosci,2009,34(1):41-54.
  • 8Faravelli C,Ambonetti A,Pallanti S,et al.Depressive relapses and incomplete recovery from index episode[J].Am J Psychiatry,1986,143(7):888-891.
  • 9Judd LL,Akiskal HS,Zeller PJ,et al.Psychosocial disability during the long-term course of unipolar major depressive disorder[J].Arch Gen Psychiatry,2000,57(4):375-380.
  • 10Judd LL,Akiskal HS,Maser JD,et al.Major depressive disorder:a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse[J].J Affect Disord.1998,50(2-3):97-108.

二级参考文献19

  • 1张传芝,李绍敏,时忠丽,于兴旺,杨冬林.影响难治性老年抑郁症危险因素的分析[J].中国神经精神疾病杂志,2004,30(4):263-263. 被引量:3
  • 2黎举红,林海程,施慎逊.首发抑郁症的近期疗效[J].上海精神医学,2002,14(4):211-213. 被引量:4
  • 3McGrath PJ,Stewart JW,Quitkin FM,王小艳.一项氟西汀治疗严重抑郁症的前瞻性研究中复发的预测[J].中国处方药,2006(10):26-27. 被引量:2
  • 4Post RM, Baldassano CF, Perlis RH, et al. Treatment of bipolar depression. CNS Spectr, 2003 ,8(12) :1.
  • 5Ghaemi SN, Rosenquist KJ, Ko JY, et al.. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry, 2004, 161( 1 ) :163.
  • 6Ghaemi SN, Hsu DJ, Soldani F, et al. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord, 2003,5 (6) :421.
  • 7Zomberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol, 1993,13(6) :397.
  • 8Keck PE Jr and McElroy SL. New approaches in managing bipolar depression.J Clin Psychiatry, 2003,64 ( suppl 1 ) : 13.
  • 9Silverstone PH, Silverstone T, A review of acute treatments for bipolar depression. Int Clin Psychopharmacol, 2004,19 (3) : 113.
  • 10Altshuler L, Suppes T, Black D, et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry, 2003, 160(7) :1252.

共引文献11

同被引文献41

  • 1粟幼嵩,陈俊,李则挚,王勇,黄佳,方贻儒,王祖承.碳酸锂联合阿立哌唑治疗双相障碍抑郁发作的疗效和安全性[J].上海交通大学学报(医学版),2011,31(11):1536-1539. 被引量:24
  • 2Kadam NS, Patil RA, Gurav AN, et al. Duloxetine Hydrochloride- Induced Oral Liehenoid Reaction: A Case Report [ J 1. Med Princ Pratt. 2015:394-397.
  • 3Cooper C, Katona C, Lyketsos K, et al. A systematic review of treatments for refractory depression in older people [ J ]. Am J Psychiatry, 2011,168(7) :6814588.
  • 4Yoshimura R, Kishi T, Hori H, et al. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients withrefractory major depressive disorder[J]. Prog Neuropsychopharmacol Biol Psychiatry,2012;39(2) :355-357.
  • 5Ahmed Kamal M, Shaheer Malik, Ahmad Ali Shaik, et al. Lipase mediated resolution of 'y-azidoalcohols in aqueous and organic media: Synthesis of (R) - and (S) -fluoxetine and duloxetine[ J]. J Mol Catal B Enzym ,2009,58 ( 1/4 ) : 132-137.
  • 6Kumar N, Sangeetha D, Vaghela B, et al. Development and validation of a stability indicating RP-LC method for the estimation of process related impurities and degradation products of duloxetine hydroehloride and phthalic acid in duloxetine hydrochloride delayed release capsules [ J~. J Liq Chromatogr Relat Techno1,2012,35 (5/8) :867-881.
  • 7Borges NC, Barrientos-Astigarraga RE, Sverdloff CE, et al. A fast, sensitive and simple method for mirtazapine quantification in human plasma by HPLC-ESI-MS/MS. Application to a comparative bioavailability study [ J ]. Biomed Chromatogr, 2012, 26 (11): 1399-1407.
  • 8魏昆岭,成玉敏,桑文华,刘增龙.度洛西汀与帕罗西汀治疗不同症状抑郁症的比较研究[J].中国临床药理学杂志,2011,27(4):252-254. 被引量:16
  • 9池思晓,王文菁,钟天平.难治性抑郁症患者症状特点与认知功能的相关性[J].广东医学,2011,32(22):2950-2952. 被引量:12
  • 10陈青松,黄喆,吴珺,谢华.文拉法辛联合米氮平治疗难治性抑郁症患者的疗效观察[J].临床精神医学杂志,2011,21(6):410-411. 被引量:21

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部